Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard?

Published:2018-04 Issue:4 Volume:1864 Page:1024-1036
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Lambrecht Joeri,Verhulst Stefaan,Mannaerts Inge,Reynaert Hendrik,van Grunsven Leo A.

Funder

Vrije Universiteit Brussel

Fund of Scientific Research Flanders

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference146 articles.

1. Needle biopsy of the liver;Nash;J. Natl. Med. Assoc.,1951

2. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection;Regev;Am. J. Gastroenterol.,2002

3. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy;Soloway;Am. J. Dig. Dis.,1971

4. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF);Cadranel;Hepatology,2000

5. Cost-effectiveness of ultrasound-guided liver biopsy;Pasha;Hepatology,1998

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets;International Journal of Medical Informatics;2024-05

2. Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease;Protein & Peptide Letters;2024-04

3. Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants;Frontiers in Nutrition;2024-02-14

4. Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning;PLOS Digital Health;2024-02-09

5. Old age as a risk factor for liver diseases: Modern therapeutic approaches;Experimental Gerontology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3